• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AbilTo Launches Tele-Behavioral Program for Substance Use

by Jasmine Pennic 01/20/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AbilTo

AbilTo, Inc., a provider of evidence-based behavioral change programs proven to improve medical health and lower cost for high-cost medical populations has announced the addition of its Depression and Substance Use program. The new program helps individuals understand the interaction between mood and substance use, and identify strategies to replace use with positive coping skills and healthy reinforcement. 

AbilTo’s Depression and Substance Use program helps participants focus on specific behaviors that influence depression and use. Participants receive non-judgmental, personalized support to modify negative behaviors and practice effective coping skills. They learn to clearly articulate their goals and find ways to increase their self-motivation and efficacy, through a deeper confidence in their ability to change. As with AbilTo’s other program offerings, licensed clinical social workers and behavior coaches provide treatment by telephone or secure video.

The National Institute on Drug Abuse has attributed $166 billion to the cost of healthcare resulting from the abuse of tobacco, alcohol and other drugs. Among those individuals with substance use disorders, sixty percent also suffer from depression. Studies have shown that behavioral change programs, such as those administered by AbilTo, can measurably reduce the cost of care and improve outcomes for these individuals.

“Behavior change, for those who suffer from substance use and depression, can be challenging,” said Aimee Peters, LCSW, chief clinical officer, AbilTo. “Our program acknowledges that the journey toward change is different for each individual, and our providers tailor their approach accordingly. This enables participants to set unique, achievable goals that get them back on the path to happier, healthier and more productive lives.”

The company recently raised $12M in Series C funding last year led by  HLM Venture Partners (HLM) and Yumin Choi, Partner along with previous investors BlueCross BlueShield Venture Partners, .406 Ventures and Sandbox Industries. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AbilTo

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |